Literature DB >> 25828950

Effects of PaCO2 derangements on clinical outcomes after cerebral injury: A systematic review.

Brian W Roberts1, Paul Karagiannis2, Michael Coletta3, J Hope Kilgannon4, Michael E Chansky5, Stephen Trzeciak6.   

Abstract

OBJECTIVE: Partial pressure of arterial carbon dioxide (PaCO2) is a major regulator of cerebral blood flow (CBF). Derangements in PaCO2 have been thought to worsen clinical outcomes after many forms of cerebral injury by altering CBF. Our aim was to systematically analyze the biomedical literature to determine the effects of PaCO2 derangements on clinical outcomes after cerebral injury.
METHODS: We performed a search of Cochrane Library, PUBMED, CINHAL, conference proceedings, and other sources using a comprehensive strategy. Study inclusion criteria were (1) human subjects; (2) cerebral injury; (3) mechanical ventilation post-injury; (4) measurement of PaCO2; and (5) comparison of a clinical outcome measure (e.g. mortality) between different PaCO2 exposures. We performed a qualitative analysis to collate and summarize effects of PaCO2 derangements according to the recommended methodology from the Cochrane Handbook.
RESULTS: Seventeen studies involving different etiologies of cerebral injury (six traumatic brain injury, six post-cardiac arrest syndrome, two cerebral vascular accident, three neonatal ischemic encephalopathy) met all inclusion and no exclusion criteria. Three randomized control trials were identified and only one was considered a high quality study as per the Cochrane criteria for assessing risk of bias. In 13/17 (76%) studies examining hypocapnia, and 7/10 (70%) studies examining hypercapnia, the exposed group (hypercapnia or hypocapnia) was associated with poor clinical outcome.
CONCLUSION: The majority of studies in this report found exposure to hypocapnia and hypercapnia after cerebral injury to be associated with poor clinical outcome. However, the optimal PaCO2 range associated with good clinical outcome remains unclear.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Brain injury; Cerebral injury; Head injury; Hypercapnia; Hypocapnia; Partial pressure of arterial carbon dioxide (PaCO(2))

Mesh:

Substances:

Year:  2015        PMID: 25828950     DOI: 10.1016/j.resuscitation.2015.03.015

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  18 in total

1.  Carbon dioxide-dependent regulation of NF-κB family members RelB and p100 gives molecular insight into CO2-dependent immune regulation.

Authors:  Ciara E Keogh; Carsten C Scholz; Javier Rodriguez; Andrew C Selfridge; Alexander von Kriegsheim; Eoin P Cummins
Journal:  J Biol Chem       Date:  2017-05-15       Impact factor: 5.157

Review 2.  ARDS in the brain-injured patient: what's different?

Authors:  Mauro Oddo; Giuseppe Citerio
Journal:  Intensive Care Med       Date:  2016-03-11       Impact factor: 17.440

Review 3.  Italian guidelines on the assessment and management of pediatric head injury in the emergency department.

Authors:  Liviana Da Dalt; Niccolo' Parri; Angela Amigoni; Agostino Nocerino; Francesca Selmin; Renzo Manara; Paola Perretta; Maria Paola Vardeu; Silvia Bressan
Journal:  Ital J Pediatr       Date:  2018-01-15       Impact factor: 2.638

4.  Partial pressure of arterial carbon dioxide and survival to hospital discharge among patients requiring acute mechanical ventilation: A cohort study.

Authors:  Brian M Fuller; Nicholas M Mohr; Anne M Drewry; Ian T Ferguson; Stephen Trzeciak; Marin H Kollef; Brian W Roberts
Journal:  J Crit Care       Date:  2017-04-26       Impact factor: 3.425

5.  Association Between Arterial Carbon Dioxide Tension and Clinical Outcomes in Venoarterial Extracorporeal Membrane Oxygenation.

Authors:  Arne Diehl; Aidan J C Burrell; Andrew A Udy; Peta M A Alexander; Peter T Rycus; Ryan P Barbaro; Vincent A Pellegrino; David V Pilcher
Journal:  Crit Care Med       Date:  2020-07       Impact factor: 7.598

6.  Association of Hypercapnia and Hypercapnic Acidosis With Clinical Outcomes in Mechanically Ventilated Patients With Cerebral Injury.

Authors:  Ravindranath Tiruvoipati; David Pilcher; John Botha; Hergen Buscher; Robert Simister; Michael Bailey
Journal:  JAMA Neurol       Date:  2018-07-01       Impact factor: 18.302

7.  Partial pressure of arterial carbon dioxide after resuscitation from cardiac arrest and neurological outcome: A prospective multi-center protocol-directed cohort study.

Authors:  J Hope Kilgannon; Benton R Hunter; Michael A Puskarich; Lisa Shea; Brian M Fuller; Christopher Jones; Michael Donnino; Jeffrey A Kline; Alan E Jones; Nathan I Shapiro; Benjamin S Abella; Stephen Trzeciak; Brian W Roberts
Journal:  Resuscitation       Date:  2018-11-16       Impact factor: 5.262

8.  Spontaneous Hyperventilation in Severe Traumatic Brain Injury: Incidence and Association with Poor Neurological Outcome.

Authors:  Pierre Esnault; Johanna Roubin; Mickael Cardinale; Erwan D'Aranda; Ambroise Montcriol; Pierre-Julien Cungi; Philippe Goutorbe; Christophe Joubert; Arnaud Dagain; Eric Meaudre
Journal:  Neurocrit Care       Date:  2019-04       Impact factor: 3.210

9.  Hyperoxia and Hypocapnia During Pediatric Extracorporeal Membrane Oxygenation: Associations With Complications, Mortality, and Functional Status Among Survivors.

Authors:  Katherine Cashen; Ron Reeder; Heidi J Dalton; Robert A Berg; Thomas P Shanley; Christopher J L Newth; Murray M Pollack; David Wessel; Joseph Carcillo; Rick Harrison; J Michael Dean; Robert Tamburro; Kathleen L Meert
Journal:  Pediatr Crit Care Med       Date:  2018-03       Impact factor: 3.624

10.  Changes in cardiac arrest patients' temperature management after the 2013 "TTM" trial: results from an international survey.

Authors:  Nicolas Deye; François Vincent; Philippe Michel; Stephan Ehrmann; Daniel da Silva; Michael Piagnerelli; Antoine Kimmoun; Olfa Hamzaoui; Jean-Claude Lacherade; Bernard de Jonghe; Florence Brouard; Corinne Audoin; Xavier Monnet; Pierre-François Laterre
Journal:  Ann Intensive Care       Date:  2016-01-12       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.